A Randomized Case-Controlled Study of Recombinant Human Granulocyte Colony Stimulating Factor for the Treatment of Sepsis in Preterm Neutropenic Infants
Pediatrics And NeonatologyPeer ReviewedDoğukan Aktaş +32014Journals
To investigate the efficacy and safety of recombinant human granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor (rhG-CSF) to treat sepsis in neutropenic preterm infants.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support